BetterLife Pharma (BETRF) Current Assets (2011 - 2026)

BetterLife Pharma has reported Current Assets for 16 years, with the latest figure at $15175.2 in Q1 2026.

• On a quarterly basis, Current Assets fell 36.93% year-over-year to $15175.2 in Q1 2026; TTM through Jan 2026 was $15175.2, a 36.93% decrease from a year earlier, with the FY2026 full-year figure at $15126.5, down 39.01% from the prior year.
• Current Assets was $15175.2 for Q1 2026 at BetterLife Pharma, down from $24061.1 in the prior quarter.
• The five-year high for Current Assets was $903006.4 in Q1 2022, with the low at $15175.2 in Q1 2026.
• Average Current Assets over 5 years is $213490.9, with a median of $121554.8 recorded in 2022.
• The largest YoY upside for Current Assets was 12.62% in 2022 against a maximum downside of 95.92% in 2022.
• Over 5 years, Current Assets stood at $206732.3 in 2022, then slumped by 73.2% to $55402.2 in 2023, then declined by 22.4% to $42991.1 in 2024, then tumbled by 44.03% to $24061.1 in 2025, then tumbled by 36.93% to $15175.2 in 2026.
• The last three Current Assets figures came in at $15175.2 (Q1 2026), $24061.1 (Q1 2025), and $42991.1 (Q1 2024), per Business Quant data.